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Abstract
Background
Sub-Saharan Africa is home to 25.8 million people living with HIV/Aids. In November 2003, the South African 
government approved The Operational Plan for Comprehensive Treatment and Care for HIV and Aids, 
which aimed to provide antiretroviral treatment to 500 000 patients by the end of 2007. The successful 
implementation of this operational plan requires many healthcare providers trained in aspects of HIV. This 
study aimed to establish and compare the views of general practitioners and pharmacists on the role of the 
pharmacist in HIV/Aids management and to elucidate an appropriate role for pharmacists. Ethical approval 
was obtained from the MEDUNSA Research Ethics and Publications Committee. 
Methods 
The study population consisted of general practitioners in the province of Gauteng and community pharmacists 
in Gauteng and the Western Cape. Two hundred medical practitioners were selected at random from the 7 
157 registered in Gauteng. Pharmacist respondents (293 from 879 community pharmacies in Gauteng and 
200 from 493 in the Western Cape respectively) were selected randomly. The respondents were contacted 
individually by telephone and asked to complete a pilot-tested 10-statement questionnaire on their views of 
aspects relating to a role for pharmacists in HIV/Aids management. 
Results
Mean values for positive responses were calculated and analysed (two-sided t test). The response rates for 
general practitioners and pharmacists were 44.5% and 38.1% respectively. The responses were grouped into 
two categories, dispensing and advice and testing and treatment. Both groups agreed about the dispensing 
and advice category. Of the general practitioners surveyed, 95.5% agreed that pharmacists should counsel 
patients on the correct use of medications and 100% agreed that the pharmacist should be aware of all 
related side effects and drug interactions of HIV medications, i.e. the general practitioners were comfortable 
with pharmacists providing a dispensing and advisory role. The groups differed significantly about the testing 
and treatment category. 
Conclusion
GPs were generally not in favour of pharmacists being involved in the testing and treatment of HIV/Aids. The 
pharmacists surveyed, on the other hand, indicated their willingness to assume an expanded role in HIV/Aids 
management. A potential role for pharmacists was elucidated. It complements the role of the pharmacist in 
HIV/Aids management described in the South African Pharmacy Council Position Paper. The differences in 
views identified in the survey hold serious implications as South Africa struggles to contend with the HIV/Aids 
epidemic.
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Introduction
Sub-Saharan Africa is home to 25.8 
million people living with HIV/Aids. 
The epidemic claimed the lives of 
approximately 2.4 million Africans in 
2005. These figures reflect the world’s 
continuing failure to counter the HIV 
pandemic.1 The lack of an adequate 
sense of urgency and of political 
leadership and commitment are addi-
tional factors affecting the spread of the 
disease.2
In November 2003, the South 
African government approved and 
launched The Operational Plan for 
Comprehensive Treatment and Care 
for HIV and Aids, which promised 
to deliver comprehensive care to 
the 5.3 million HIV-positive people 
in the country, including providing 
antiretroviral treatment. By the end 
of 2007, the government planned to 
provide antiretroviral therapy to 500 000 
patients. Achieving this goal will require 
many healthcare providers trained in 
aspects of HIV management.3,4 
The aim of this study was to establish 
the views of general practitioners and 
pharmacists and to elucidate a role for 
pharmacists in HIV/Aids management.  
Method
Study population and sampling
Ethical approval for this research study 
was obtained from the Research Ethics 
and Publications Committee of the 
MEDUNSA Faculty of Medicine. 
The target population of general 
practitioners in Gauteng was identified in 
2003, comprising general practitioners 
who were registered with the Health 
Professions Council of South Africa (7 
157). Two hundred respondents were 
selected at random from this list to 
obtain 100 usable responses. 
The target population of community 
pharmacists was taken from Gauteng 
and the Western Cape. The Western 
Cape group was subsequently used 
as the control group for another study. 
The two groups were combined in the 
study described in this paper. A list of all 
community pharmacies in Gauteng and 
the Western Cape was obtained from 
the South African Pharmacy Council. 
Statistical advice indicated that a total 
of 150 usable responses was necessary 
for Gauteng. To obtain this number, 293 
pharmacies were randomly selected 
from 879 community pharmacies 
in the province. Statistical advice 
gave a total of 100 usable responses 
necessary for the Western Cape. To 
obtain this number, 200 pharmacies 
were randomly selected from 412 
community pharmacies in the province. 
The combined sample consisted of 493 
pharmacists.
Measurements
All the respondents were contacted 
telephonically to establish their 
willingness to participate. After pilot 
testing with four general practitioners 
and five pharmacists, the questionnaire, 
accompanied by a covering letter, 
was mailed, e-mailed or faxed to the 
participants. The respondents were 
asked to return the completed question-
naires by fax. The questionnaire, which 
was adapted from Katz et al.,5 covered 
demographic details and included 10 
questions (requiring a “yes” or “no” 
response) on the respondent’s views 
of the role of pharmacists in HIV/Aids 
management. The 10 questions are 
listed in Tables II and III. General 
practitioners and pharmacists who did 
not respond to the first request were 
contacted again after three weeks and 
asked to complete the questionnaires. 
The purpose of the follow-up contact 
was to increase the response rate.
Statistical analysis
All “yes” responses were allocated a 
score of one and negative responses 
were allocated a score of zero. A 
maximum score of 10 positive responses 
was possible (100%). Individual scores 
were expressed as a mean percentage 
per question. A mean score was 
calculated for the respondents for all 
10 questions. These mean values were 
used to determine whether the views of 
general practitioners and pharmacists 
were statistically significantly different 
(two-sided t test) on the role of 
pharmacists in HIV/Aids management. 
The responses were grouped into two 
categories (Dispensing/Advice and 
Testing/Treatment) and also compared 
for statistical significance by means of a 
two-sided Fischer exact test. Individual 
questions were similarly compared.
Results
The total number of responses received 
from general practitioners was 89/200 
(44.5% response rate). The total number 
of responses received from pharmacists 
was 188/493 (38.1% response rate). 
Conclusions regarding the views of 
general practitioners and pharmacists 
are based on the responses obtained 
during this research study.
Table I and Figure 1 illustrate that 
there was a significant difference 
(p<0.001) in the total mean scores 
between the general practitioners 
and the pharmacists. The trend of the 
difference indicated that the general 
practitioners surveyed had a less 
positive view than pharmacists about the 
role of pharmacists in the management 
of HIV/Aids. 
Table I: Comparison of total mean opinion scores for general practitioners and 
pharmacists  
*Statistically highly significant
Figure 1: Comparison of total mean opinion scores for general practitioners and 
pharmacists  
*Statistically highly significant
Group Mean score Standard 
deviation
Probability
General practitioners (n=89) 4.75 1.85
Pharmacists (n=188) 6.21 2.15
p<0.001*
SA Fam Pract 2006:48(7)14 b
Original Research
The 10 questions were then grouped 
into two categories. Questions 1, 2, 8 
and 9 referred to dispensing and advice. 
Questions 3, 4, 5, 6, 7 and 10 comprised 
the testing and treatment category. 
Table II and Figure 2 indicate the total 
number of “yes” responses per question 
on dispensing and advice, expressed 
as a percentage of the replies.
Dispensing and advice
Overall, there was very little difference 
between the mean percentage of 
positive responses for the two groups. 
Table II illustrates that the difference 
between the general practitioners 
and pharmacists was not significant 
(p=0.747). This result confirms that 
both the general practitioners and 
the pharmacists are comfortable with 
pharmacists performing a dispensing 
and advisory role in the management of 
HIV/Aids patients. 
As far as individual questions are 
concerned, the vast majority of the 
general practitioners (95.5%) and 









% difference p value
1.  Before dispensing HIV medication, 
should the pharmacist contact the 
prescriber to discuss the treatment?
69.7 41.8 27.9 <0.001*
2.  Should the pharmacist counsel patients 
on the correct use of medication? 95.5 98.9 3.4 0.086
8.  Should the pharmacist be aware 
of all related side effects and drug 
interactions with HIV medications?
100 98.9 1.1 1.000
9.  Should pharmacies be equipped as 
HIV information sites with separate 
consultation areas?
56.8 76.8 20 0.001*
Mean 80.6 79.7 0.9 0.747
* Statistically highly significant
Figure 2: Percentage positive responses per question for general practitioners 
(n=89) and pharmacists (n=188) on Dispensing and Advice
* Statistically highly significant
pharmacists (98.9%) agreed that 
pharmacists should counsel patients on 
the correct use of medications (question 
2). Both groups also agreed that the 
pharmacist should be aware of the side 
effects of and drug interactions with HIV 
medications (question 8). 
Most of the pharmacists surveyed 
(76.8%) endorsed the concept of 
pharmacies as HIV information 
centres (question 9), whereas general 
practitioners (56.8%) were not in favour. 
This difference was significant (p=0.001). 
A second major difference between the 
two groups of respondents occurred in 
response to question 1. In this case, the 
majority of doctors surveyed (almost 
70%) wanted pharmacists to discuss 
treatment regimens with them before 
dispensing medication. Only 41.8% of 
pharmacists supported this step. The 
difference between the responses was 
significant.
Table III and Figure 3 indicate the 
total number of “yes” responses per 
question in the testing and treatment 
category, expressed as a percentage 
of replies.
Testing and treatment
The difference between the mean 
percentage of positive responses for 
this group of questions was significant 
(p<0.001). This result indicates that the 
pharmacists surveyed were willing to 
perform an expanded role in the testing 
and treatment of HIV/Aids patients. 
However, the general practitioners 
were not in favour of pharmacists 
being involved in such a role. A 
detailed examination of the individual 
responses to the questions shows 
clearly that pharmacists are positive 
about the extended role. For five of 
the six questions asked, the difference 
between the responses was significant.
Discussion
An opinion or view can be defined as 
what one thinks or believes about a 
particular topic or question.6 It generally 
reflects one’s background, knowledge 
(or lack thereof), self-interest and 
prejudices. The survey described in this 
paper established the views of some 
general practitioners and pharmacists 
about what they believed the role of 
pharmacists in HIV/Aids management 
should be. These views differ 
considerably. They reflect a tension that 
is possibly associated, on the one hand, 
with entrenched positions (the medical 
practitioners) and, on the other, with 
frustration at the potentially diminishing 
role of the pharmacist in dispensing, 
hence the need for participation in 
other activities. Both of these positions 
are linked to economic outcomes.
These views, and the associated 
tension, could impact negatively on 
progress as the country attempts to 
deal with the HIV/Aids crisis. Are the 
views of the general practitioners too 
SA Fam Pract 2006:48(7) 14 c
Original Research









% difference p value
3.  Should the pharmacist have access to 
the patient’s laboratory test results?
34.8 41.8 7 0.2935
4.  Should the pharmacist do pre-test 
counselling?
34.1 61.1 27 <0.001*
5.  Should the pharmacist do HIV rapid 
tests and interpretation thereof to 
diagnose HIV?
15.9 37.7 21.8 <0.001*
6.  Should the pharmacist provide post-
exposure prophylaxis (treatment after 
accidental exposure to HIV infected 
blood e.g. needle stick injuries, 
rape) to patients, without a doctor’s 
prescription?
37.1 62.1 25 <0.001*
7.  Should the pharmacist be allowed to 
treat sexually transmitted diseases 
without a doctor’s prescription?
6.7 55.7 49 <0.001*
10.  Should pharmacists be registered as 
preferred HIV treatment providers?
26.4 61.4 35 <0.001*
Mean 25.8 53.3 27.5 <0.001*
Figure 3: Percentage of positive responses per question for general practitioners 
(n=89) and pharmacists (n=188) on Testing and Treatment 
* Statistically highly significant
* Statistically highly significant
conservative? Is there in fact a need 
to expand the roles of all healthcare 
providers in the crisis that faces South 
Africa? Will treatment reach the targeted 
numbers if all practitioners are not used 
to the optimum? Are pharmacists poorly 
prepared for what they obviously see as 
an expanded role?
Other work has explored possible 
answers to some of these questions. For 
example, a related study has shown that 
pharmacists may not have an adequate 
level of knowledge in some aspects 
of testing, counselling, treatment and 
compliance.7 These knowledge gaps 
will have to be dealt with if pharmacists 
are to be able to perform a proper role. 
It is unfortunate that no similar work 
has been carried out on the HIV/Aids 
knowledge base of general practitioners 
in South Africa, considering the views 
of those who participated in the survey 
described in this paper.
The proposed antiretroviral treatment 
plan of the Department of Health 
requires 28 doctors to treat every 10 
000 patients. Hence, by the end of 
2007, the public health system will 
require 1 400 additional doctors to 
handle the target of 500 000 patients 
on antiretroviral treatment, never mind 
the numbers of other professionals. 
This system is already challenged by 
inadequate resources and the burden 
of the disease. Recruiting medical 
practitioners is difficult. It is therefore 
vital for pharmacists, and all other 
healthcare practitioners, to be involved 
and to make a substantive contribution 
to HIV/Aids management.3,4 
The results of this survey have 
also been used to elucidate a 
potential role for pharmacists in HIV 
management. The responses from the 
pharmacists (see Tables II and III) were 
predominantly positive regarding the 
following aspects:
•  Counselling patients on the correct 
use of medication
• Performing pre-test counselling
•  Providing post-exposure prophylaxis
•  Being aware of side effects and drug 
interactions 
•  Utilising pharmacies as HIV 
information centres
•  Utilising pharmacies as registered 
preferred HIV treatment providers
This positive view indicates that 
pharmacists are willing to pursue an 
expanded role. What support is there 
for this view?
The South African Pharmacy Council 
has released a Position Paper on the role 
of the pharmacist in the management 
of HIV/Aids, TB and STIs. This paper 
covers four main areas:
• Prevention 
• Treatment, care and support 
• Human and legal rights 
•  Monitoring, surveillance and research8 
Similar views have been expressed in 
other countries. In the USA in 1999, 
Zappa conceptualised a new model 
for pharmacists in HIV management 
that concentrates on drug-related 
activities, information provision and 
patient confidentiality.9 This model uses 
the pharmacy as the focal point for 
care and calls it a community-based 
care centre. The aim is to identify 
patients at risk before they become 
severely ill. The pharmacist must then 
provide services that complement 
those offered by the primary HIV/Aids 
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doctor. The pharmacist will be an expert 
in the management of patients with 
HIV/Aids and take responsibility for all 
drug-related issues. These include: 
reviewing prescriptions, recommending 
changes when appropriate, monitoring 
adherence, managing adverse events, 
educating other team members on 
new drug information and ensuring 
the availability of medication. This 
specialised pharmacist would also 
educate non-infected people about 
identifying and minimising the risks of 
HIV transmission. The primary HIV/Aids 
doctor would work with the pharmacist in 
this model to emphasise the importance 
of adherence to treatment. Zappa’s 
rationale for the role of the pharmacist 
as a primary caregiver in HIV/Aids 
management includes the following 
factors:
1.  The pharmacist is often the most 
accessible healthcare provider in the 
community for offering both treatment 
and education.
2.  Pharmacists are trusted experts in 
drug therapy.10
The postulated SA Pharmacy 
Council model is similar to the model 
conceptualised by Zappa in all core 
areas. Both models concentrate on 
drug-related activities, information 
provision and patient confidentiality. 
The opinions of the pharmacists in 
this survey match the proposed roles 
recommended by Zappa9 and the SA 
Pharmacy Council,6 as illustrated in 
Table IV.
To perform this pivotal role in HIV 
management, pharmacists must have 
the necessary knowledge at their 
disposal. A positive attitude towards HIV 
patients and preparedness to advise 
these patients are essential elements for 
Table IV: Comparisons of defined roles for pharmacists in HIV management
Zappa (1999) SA Pharmacy Council criteria (2003) Responses of this survey
Responsible for all drug-related 
activities
Supply antiretrovirals, manage tuberculosis 
and treatment of opportunistic infections
Dispense medication
Be aware of side effects and drug interactions
Counsel patients on correct use of medication
Supply products, services and 
information in one place
Provide prevention, treatment, care and 
support services
Provide post-exposure prophylaxis
Focus on education, prevention and 
screening programmes
Provide voluntary testing and counselling Do pre-test counselling
Include services of a nutritionist and 
a nurse, and complement services 
provided by the medical doctor
Monitor complications and referrals for 
medical intervention
Pharmacies as HIV information centres
Pharmacies as registered preferred HIV 
treatment providers
Ensure patient confidentiality Ensure patient confidentiality and privacy
the pharmacist to perform a successful 
role in the management of HIV/Aids. 
The main limitation of the study was 
the size and geographical focus of the 
sample, which was due to practical 
considerations, time constraints and 
a limited budget. Nevertheless, the 
results demonstrate considerable 
positive outcomes. The opinions of 
other healthcare workers, e.g. nurses 
and social workers, should also be 
investigated. Similarly, HIV/Aids disease 
management organisations can provide 
important information on real-life 
experiences and areas where they have 
identified the need for an expanded role 
for pharmacists in HIV management. 
The results of this survey can be 
used as a point of departure to further 
define the role of pharmacists in HIV 
management. For maximum benefit, 
this expanded role should then be 
introduced to all members of the 
healthcare team. It is also imperative 
that pharmacists themselves expand 
and optimise their services to actively 
pursue their full role in HIV and Aids 
care.
Conclusion 
At a time when the efforts of all health 
professionals must be harnessed to 
counteract the Aids epidemic in South 
Africa, pharmacists have not been 
shown to contribute significantly. Part of 
the problem may be as a consequence 
of the poor perception by general 
practitioners about an expanded role 
for pharmacists in the management of 
HIV/Aids. Another factor may be that 
pharmacists lack specific knowledge. 
Once an extended role is defined, the 
next step is to ensure that pharmacists 
are equipped with the necessary 
knowledge, attitudes and preparedness 
to advise and manage HIV patients. 
Some of these issues have already been 
explored by the authors.7
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